These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34091541)

  • 1. A Collaborative Effort to Advance Drug Development in Pediatric Constipation and Irritable Bowel Syndrome.
    Saps M; Nurko S; Benninga MA; Di Lorenzo C; Garza JM; Thapar N; Richards K; Lee JJ; Altepeter T
    J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):145-149. PubMed ID: 34091541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Fiber in the Treatment of Functional Gastrointestinal Disorders in Children.
    Axelrod CH; Saps M
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome.
    Chang L; Lembo A; Sultan S
    Gastroenterology; 2014 Nov; 147(5):1149-72.e2. PubMed ID: 25224525
    [No Abstract]   [Full Text] [Related]  

  • 4. American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome.
    Weinberg DS; Smalley W; Heidelbaugh JJ; Sultan S;
    Gastroenterology; 2014 Nov; 147(5):1146-8. PubMed ID: 25224526
    [No Abstract]   [Full Text] [Related]  

  • 5. Rome foundation Asian working team report: Real world treatment experience of Asian patients with functional bowel disorders.
    Xiong L; Gong X; Siah KT; Pratap N; Ghoshal UC; Abdullah M; Syam AF; Bak YT; Choi MG; Lu CL; Gonlachanvit S; Chua ASB; Chong KM; Ricaforte-Campos JD; Shi Q; Hou X; Whitehead WE; Gwee KA; Chen M
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1450-1456. PubMed ID: 28084664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plecanatide for the treatment of constipation-predominant irritable bowel syndrome.
    Miner PB
    Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):71-84. PubMed ID: 31985305
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
    Shah E; Kim S; Chong K; Lembo A; Pimentel M
    Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lubiprostone: RU 0211, SPI 0211.
    Drugs R D; 2005; 6(4):245-8. PubMed ID: 15991886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP).
    Barbara G; Cremon C; Bellini M; Corsetti M; Di Nardo G; Falangone F; Fuccio L; Galeazzi F; Iovino P; Sarnelli G; Savarino EV; Stanghellini V; Staiano A; Stasi C; Tosetti C; Turco R; Ubaldi E; Zagari RM; Zenzeri L; Marasco G
    Dig Liver Dis; 2023 Feb; 55(2):187-207. PubMed ID: 36517261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plecanatide for Treatment of Chronic Constipation and Irritable Bowel Syndrome.
    Love BL
    Am J Med; 2019 May; 132(5):572-575. PubMed ID: 30550753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.
    Love BL; Johnson A; Smith LS
    Am J Health Syst Pharm; 2014 Jul; 71(13):1081-91. PubMed ID: 24939497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation.
    Liu JJ; Brenner DM
    Gastroenterol Clin North Am; 2021 Sep; 50(3):639-653. PubMed ID: 34304792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenapanor for constipation-predominant irritable bowel syndrome.
    Siddiqui S; Cash BD
    Drugs Today (Barc); 2020 Mar; 56(3):203-210. PubMed ID: 32282867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conceptualization and treatment of chronic abdominal pain in pediatric gastroenterology practice.
    Schurman JV; Hunter HL; Friesen CA
    J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):32-7. PubMed ID: 19915496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
    Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
    Semergen; 2017 Mar; 43(2):123-140. PubMed ID: 28189496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
    Mearin F; Ciriza C; Mínguez M; Rey E; Mascort JJ; Peña E; Cañones P; Júdez J;
    Aten Primaria; 2017 Mar; 49(3):177-194. PubMed ID: 28238460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
    Videlock EJ; Cheng V; Cremonini F
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Entrustable Professional Activities and Standards in Training in Pediatric Neurogastroenterology and Motility: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and American Neurogastroenterology and Motility Society Position Paper.
    Khlevner J; Rosen R; Ambartsumyan L; Lusman SS; Rosen JM; Yacob D; Mousa H; Nurko S; Di Lorenzo C; Boruta M; Ratcliffe EM; Feinstein L; Snyder J; Wood RJ; Graham K; Saps M; Gyawali CP; Rodriguez L; Belkind-Gerson J
    J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):168-180. PubMed ID: 33075010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.